J&J $6.5 Billion Momenta Pact Is Year’s Biggest Pharma Deal
Signage is displayed outside Johnson & Johnson headquarters in New Brunswick, New Jersey, U.S. (Photographer: Mark Kauzlarich/Bloomberg)

J&J $6.5 Billion Momenta Pact Is Year’s Biggest Pharma Deal

(Bloomberg) -- Johnson & Johnson agreed to pay $6.5 billion in cash to acquire Momenta Pharmaceuticals Inc., a maker of autoimmune-disease drugs, in the largest pharmaceutical-industry merger this ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.